- A Case of Successful Primary Coronary Intervention for the Total Occlusion of Left Main Stem with the Aid of Abciximab
-
Jeong MH, Ahn YK, Park JC, Ahn BH, Na KJ, Kim NH, Kim KH, Cho JG, Park JC, Kim SH, Kang JC
- KMID: 648312
- J Korean Med Sci.
- 2001 Aug;16(4):509-511.
- doi: 10.3346/jkms.2001.16.4.509
A 61-yr-old male patient presented with severe chest pain with cardiogenic shock due to an extensive anterolateral myocardial infarction. Two-dimensional echocardiogram showed severe left ventricular systolic dysfunction (ejection fraction=17%). Emergent... -
- CITED
-
- Close
- SHARE
-
- Close
- The Long-term Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro (R) ) Coated Stent in Patients with Coronary Artery Disease
-
Kim W, Jeong MH, Hong YJ, Lee SH, Park WS, Kim JH, Kim IS, Choi MJ, Ahn YK, Cho JG, Park JC, Cho DL, Kim H, Kang JC
- KMID: 1109520
- Korean J Intern Med.
- 2004 Dec;19(4):220-229.
BACKGROUND: Previously, the inhibition of coronary restenosis with Abciximab (ReoPro (R) ) -coated stent in a porcine model was reported. ReoPro (R) inhibits platelet aggregation, the proliferation of vascular smooth... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Clinical Benefits of a Platelet Glycoprotein IIb/IIIa Receptor Blocker, Abciximab (ReoPro (R) ), in High-Risk Diabetic Patients undergoing Percutaneous Coronary Intervention
-
Sim DS, Jeong MH, Kim W, Rhew JY, Yum JH, Kim JH, Cho JG, Ahn YK, Park JC, Ahn BH, Kim SH, Kang JC
- KMID: 759651
- Korean J Intern Med.
- 2003 Sep;18(3):129-137.
BACKGROUND: High-risk percutaneous coronary interventions (PCIs) are associated with a high complication rate, a low procedural success rate and a high restenosis rate, especially in diabetics. We sought to determine... -
- CITED
-
- Close
- SHARE
-
- Close
